Partial
Partially Aligned
Patient Risk:
Moderate
Summary
Several dosing/administration statements match general label concepts (IV infusion, once weekly, missed dose timing as ‘as soon as possible’), but the recommended dose is incorrect (stated 20 mg/kg vs labeled 30 mg/kg). Other claims about labeling content and renal/lab-based dose adjustment are also not supported by the provided label excerpts.
Category Scores
Accurate Statements
Vyondys 53 (golodirsen) is administered as an intravenous (IV) infusion.
Label Section 2 (Dosage and Administration) indicates dosing as an intravenous infusion.
Vyondys 53 (golodirsen) is typically administered once weekly.
Label Section 2.2: recommended dosage is administered once weekly.
The prescribed dose is based on the patient’s actual body weight.
Label Section 2.2: recommended dosage is mg per kilogram.
Vyondys 53 product labeling provides guidance on what to do if a dose is missed, including when to resume routine weekly dosing.
Label Section 2.2: If a dose is missed, it may be administered as soon as possible after the scheduled dose.
The product information specifies how Vyondys 53 (golodirsen) should be prepared and infused.
Label excerpt includes administration instructions (e.g., inline 0.2 micron filter and infusion guidance) within Dosage and Administration.
Unsupported Statements
The recommended dosage of Vyondys 53 (golodirsen) is 20 mg per kg of body weight.
Label Section 2.2 states the recommended dosage is 30 mg/kg once weekly, not 20 mg/kg.
Dose (mg) = 20 × body weight (kg) for Vyondys 53 (golodirsen).
Label Section 2.2 does not provide a 20 mg/kg regimen; it specifies 30 mg/kg once weekly.
A 25 kg patient would receive 500 mg per week with Vyondys 53 (golodirsen) using 20 mg/kg.
This calculation depends on an incorrect 20 mg/kg dose; label specifies 30 mg/kg.
Dose adjustment from the labeled 20 mg/kg regimen is generally not described as being based on routine lab values.
The label excerpt does not describe any ‘20 mg/kg’ labeled regimen, and it does describe kidney monitoring rather than routine lab-based dose adjustment in the provided text.
Contradictions
Low
AI Statement
The recommended dosage of Vyondys 53 (golodirsen) is 20 mg per kg of body weight.
Label Reference
Label Section 2.2: recommended dosage is 30 milligrams per kilogram administered once weekly as a 35 to 60-minute IV infusion.
Important Omissions
The labeled dose is 30 mg/kg once weekly, with administration as a 35 to 60-minute IV infusion via an in-line 0.2 micron filter (and the missed-dose wording does not necessarily include ‘resume routine weekly dosing’ beyond administering as soon as possible).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
An incorrect stated dose (20 mg/kg instead of labeled 30 mg/kg) could materially affect safety/efficacy if followed.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Partially Aligned
Primary Issue
Incorrect recommended dose and downstream dosing calculations (20 mg/kg vs labeled 30 mg/kg).
Suggested Improvement
Replace all 20 mg/kg statements and related calculations with the label’s recommended 30 mg/kg once-weekly regimen, including the labeled infusion duration (35–60 minutes) and inline 0.2 micron filter, as reflected in the provided label excerpt.